Navigation Links
Researchers make the invisible visible
Date:2/24/2014

The 2003 development of the so-called hyperpolarization technique by a Danish research was a groundbreaking moment that made it possible to see all the body's cells with the help of a new contrast agent for MRI scans. Researchers from Aarhus have now taken another big step towards understanding the body's cells and with it also the development of diseases:

"With the hyperpolarization method, sensitivity to specific contrast agents is up to 10,000 times higher than with a traditional MRI scanning. What we have now documented is that with the hyperpolarization MRI scanning we can not only see the differences in the metabolic patterns between healthy and ill, but we now can also see the metabolic changes as a consequence of acute influences while they are taking place in the diabetic kidneys. It is really groundbreaking," says Assistant Professor Christoffer Laustsen from Aarhus University.

The discovery stems from a study of the correlation between oxygen level and the development of kidney disease in rats with and without diabetes. The findings have just been published in the prestigious international journal Kidney International.

Tailored treatment

Though the advanced hyperpolarization technique has initially been utilised to document metabolic changes in the kidneys, it will be possible to use it to gain a greater insight into the development of diseases in all of the body's organs:

"With this method we will have a fingerprint of the cells and we will be able to follow whether these fingerprints change over time, regardless of which organs we examine. We will, for example, be able to see whether complications related to diabetes and cardiovascular diseases are emerging, or how a cancer tumour develops," says Christoffer Laustsen and continues:

"And with greater knowledge of what is always going on at the cellular level we will be able to make a diagnosis earlier than we can today, and we will also be able to tailor treatment to the individual patient to a greater extent."

Better diagnosis of childhood diseases

The advantage of hyperpolarization scanning is not only that it provides the researchers with much greater detail about what is going on in the body. The new method can also prove to be very important for the smallest patients in particular:

"Another great advantage of this method is that this is quite harmless. The contrast agent for the hyperpolarization scanning is sugar-based, so there is no risk of the body tissues being exposed to radiation. It will therefore be possible to scan children more often than today," says Christoffer Laustsen.

He has carried out the study with fellow researchers from Aarhus University, Aarhus University Hospital, the Technical University of Denmark, Hvidovre Hospital and Uppsala University.

The studies of metabolic changes at the cellular level have so far been carried out on rats. Christoffer Laustsen however expects that researchers in Denmark - which is one of the leading countries in Europe in the area - will be ready to offer diagnostic examination of patients within 2-3 years.


'/>"/>

Contact: Christoffer Laustsen
cl@mr.au.dk
45-78-45-61-06
Aarhus University
Source:Eurekalert  

Related medicine news :

1. Researchers look for culprit behind oral health problems in HIV-positive patients
2. Clemson researchers develop sticky nanoparticles to fight heart disease
3. NUS researchers make new discovery of protein as a promising target for treatment of ATC
4. Scripps researchers recommend mobile compression device to prevent DVT after joint surgery
5. No such thing as porn addiction, researchers say
6. LA BioMed researchers report on promising new therapy for devastating genetic disorder
7. NIH-funded researchers use antibody treatment to protect humanized mice from HIV
8. Researchers blend orthopedics, engineering to better repair torn rotator cuffs
9. Researchers discover new hormone receptors to target when treating breast cancer
10. Kessler Foundation MS researchers study predictors of employment status
11. RI Hospital researchers identify components in C. diff that may lead to better treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers make the invisible visible
(Date:4/28/2017)... ... April 28, 2017 , ... ... with the Home Care Association of America (HCAOA). This agreement allows HCAOA members ... services, as well as discounts on Accreditation University (AU) educational resources that help ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... 2017 Solentim, the developer of instrumentation ... of a major new product line called the ... VIPS has been developed for automatically seeding single ... part of the process to generate clonally-derived cell ... more reliable solution when compared to traditional single ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: